Rarity Bioscience - Latest updates

CEO Linus Bosaeus, CTO Lei Chen and Dir. BD Alexander Kele attended the ISMRC (International Symposium on Minimal Residual Cancer) Conference in Hamburg,

CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the AML Conference in Munich, Germany 2023, to engage

We are aiming at radically improving cancer diagnostic and are expanding our Research and Development team, we need you as

Using the superRCA technology, you can essentially detect any known sequence of interest using target specific ligation templates and padlock

Last spring, Rarity was awarded a grant from Swelife and Medtech4Health. The idea is to study superRCA for precision diagnostics

To further accelerate growth, Rarity Bioscience announces today a new strategicinvestment from Belgium based Novalis Biotech. The investment is facilitated

With the aim to improve cancer diagnostics, Rarity Bioscience has raised €2,5 million to expand operations and product development within

During November, Rarity Bioscience offer free analysis of liquid biopsy samples for cancer research. Movember is a month-long event to

Speed of Life is a podcast series focusing on innovations accelerating towards better health, by STUNS Life Science. It’s sponsored

Rarity Bioscience was founded in July 2021 based on an innovation by Dr. Lei Chen and Professor Ulf Landegren. Linus

CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the European Society for Medical Oncology Congress 2022, to

We are delighted to share that Dr. Lei Chen has been awarded the prestigious Skapa innovation award, as winner of

With an innovative, super sensitive technology, so-called superRCA, remaining cancer cells can be detected after treatment of acute myeloid leukemia

Inte ens ett år gamla har Rarity Bioscience fått anslag från Swelife och Medtech4health. Nu hoppas Linus Bosaeus, vd på

On behalf of the sponsor, Elicera Therapeutics, Rarity is supporting the ELC301 translational study with analysis of the vector copy

Poster presentation by Lei Chen,PhD at the European Association for Cancer Research (EACR) conference on Liquid Biopsy in Bergamo, Italy.

The award from Uppsala University Innovation goes to startup companies that has successfully attracted external funding and made technological advancements.

Rarity has been awarded a grant from Swelife and Medtech4Health – Collaboration project for better health, fall 2021. The project is